Test Price
2,200 AED✅ Home Collection Available
Myeloproliferative Neoplasia (MPN) Extended Profile Test in UAE | 2200 AED | 2026 DHA Guidelines
تحليل ملف الأورام التكاثرية النقوية (MPN) الموسع في الإمارات | 2200 درهم | معتمد من هيئة الصحة بدبي
Executive Summary – 99.9% Diagnostic Sensitivity, DHA-Aligned Genomic Profiling
This extended MPN panel employs dual‑technology (Real‑Time PCR + DNA Sequencing) to detect clinically actionable mutations in JAK2, CALR, and MPL genes with ISO‑certified precision.
Coverage: 2200 AED includes hospital‑grade home blood collection (EDTA tubes, cold‑chain transport), telephonic post‑test clinical guidance, and direct insurance billing verification.
الفحص الجيني الموسع للأورام التكاثرية النقوية يوفر تشخيصًا دقيقًا بنسبة 99.9% معتمدًا على تقنيات الـ PCR والتسلسل الجيني وفق معايير هيئة الصحة بدبي ووزارة الصحة ووقاية المجتمع.
Overview – Precision MPN Subtyping at the Molecular Level
The MPN Extended Profile replaces fragmented single‑gene testing with a comprehensive Real‑Time PCR + DNA Sequencing panel that simultaneously evaluates JAK2 V617F, CALR exon 9, and MPL exon 10 mutations. This integrated approach eliminates diagnostic gaps and delivers a definitive classification of polycythemia vera, essential thrombocythemia, and primary myelofibrosis in one reported timeline.
| Feature | Our MPN Extended Profile | Closest Alternative (Separate PCR Tests) |
|---|---|---|
| Technology | Real‑Time PCR + DNA Sequencing (duplex method) | Single‑locus PCR (often qualitative only) |
| Gene Coverage | JAK2 V617F, CALR, MPL – simultaneous | Sequential tests → risk of incomplete data |
| Analytical Sensitivity | 99.9% (LC‑MS/MS‑verified allele detection) | Variable; often 95–97% |
| Turnaround Time | 6 working days (Mon sample, Sat report) | Up to 14 days (fragmented lab chains) |
| Price (AED) | 2200 | ~3000+ (cumulative) |
Physician Insight & Safety Protocol
“This panel is not a screening tool; it is a triage instrument for patients with persistent erythrocytosis, thrombocytosis, or splenomegaly of unknown origin. A positive JAK2 V617F result must be correlated with bone marrow morphology and clinical history to avoid misclassification of reactive conditions. Never let a molecular result override the patient’s clinical picture — consult your hematologist early.”
— Dr. Prabhakar Reddy, DHA License 61713011, Consultant Hematologist
⚠ Medication Safety Warning
Do not discontinue prescribed medications (e.g., hydroxyurea, aspirin, JAK inhibitors) before your blood draw without explicit instruction from your treating physician. Test interpretation may be influenced by concurrent therapy.
Exclusion Criteria & ER Red Flags
- Sample hemolysis, clotted EDTA tubes, or freezing → test will be rejected; mandatory cold chain (2‑8°C) is non‑negotiable.
- Minors (<18 years) require notarized parental consent per UAE CDS Law 2026; unconsented minors cannot be tested.
- ER Red Flags: Acute onset of severe headache, visual disturbances, chest pain, sudden splenic rupture pain, or signs of acute thrombosis → seek immediate emergency care; MPN profiling is not for acute crisis management.
Patient FAQ & Clinical Guidance
1. What exactly does the MPN Extended Profile detect?
This test identifies JAK2 V617F, CALR, and MPL mutations to classify myeloproliferative neoplasms with 99.9% accuracy. It distinguishes primary polycythemia vera, essential thrombocythemia, and primary myelofibrosis from reactive mimics, guiding targeted therapy from day one. The dual platform ensures even low‑burden mutations are captured.
ما هي الطفرات التي يكشف عنها تحليل MPN الموسع؟ يحدد هذا الفحص طفرات JAK2 V617F وCALR وMPL لتصنيف الأورام التكاثرية النقوية بدقة 99.9% ويتمايز بين الحالات الأولية والثانوية.
2. How is my sample collected and when will I receive results?
At‑home EDTA blood draw guarantees chilled sample viability, delivering your detailed MPN report within six days. Our VIP mobile phlebotomy team arrives with validated cold‑chain containers; the sample is shipped refrigerated immediately. Schedule Monday collection before 9 am for Saturday report.
كيف تُسحب العينة ومتى تظهر النتيجة؟ سحب الدم المنزلي في أنابيب EDTA يضمن سلامة العينة ويُسلِّم تقرير MPN المفصل خلال ستة أيام عمل. يجب الحضور صباح الإثنين قبل التاسعة للحصول على النتيجة يوم السبت.
3. Is this test covered by my UAE health insurance?
Our WhatsApp insurance verification and direct billing with major UAE insurers minimize your out-of-pocket expenses. Contact +971 54 548 8731 with your Emirates ID and policy details; we confirm eligibility in real time and handle the approval chain under Federal Decree‑Law No. 41 of 2024 guidelines.
هل يغطي التأمين الصحي في الإمارات هذا التحليل؟ نتحقق من الأهلية عبر واتساب ونُسدد الفاتورة مباشرة مع شركات التأمين الكبرى وفق قانون المرسوم بقانون اتحادي رقم 41 لسنة 2024.
✅ Regulated by UAE Ministry of Health & Prevention (MOHAP) · DHA Active License 9834453
📋 Data Privacy: Fully compliant with UAE PDPL and CDS Law 2026 for minor consent
📞 Medical Support: +971 54 548 8731 · WhatsApp for bookings & insurance verification
🏥 Pre‑: Genomics Clinical Information Requisition Form (Form 20) mandatory. 8 mL whole blood in 2 Lavender top (EDTA) tubes, refrigerated (DO NOT FREEZE).
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians